161 The results of the Phase II clinical trials of retatrutide were published in The Lancet in 2023
What is the GLOW Blend
Kohlmeyer JL, Kaemmer CA, Pulliam C, Maharjan CK, Samayoa AM, Major HJ, et al
Acta Neuropathol (2010) 120:755
Cerebrospinal Fluid (CSF) Analysis CSF analysis remains a gold standard for assessing neurotransmitter imbalances, especially when investigating conditions like Alzheimer's disease
If it does not improve, your provider can evaluate a slight dose reduction, advise reducing caffeine and other stimulants, or discuss alternative appetite suppressants such as Tenuate or Phendimetrazine, which work through different mechanisms and tend to cause less sleep disruption